Zymeworks Inc.
ZYME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $76,304 | $76,012 | $412,482 | $26,680 |
| % Growth | 0.4% | -81.6% | 1,446% | – |
| Cost of Goods Sold | $0 | $142,989 | $0 | $0 |
| Gross Profit | $76,304 | -$66,977 | $412,482 | $26,680 |
| % Margin | 100% | -88.1% | 100% | 100% |
| R&D Expenses | $134,621 | $143,619 | $208,596 | $199,752 |
| G&A Expenses | $61,500 | $70,400 | $73,400 | $42,600 |
| SG&A Expenses | $61,500 | $70,400 | $73,400 | $42,600 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $17,293 | -$142,943 | -$42 | -$39 |
| Operating Expenses | $213,414 | $71,076 | $281,954 | $242,313 |
| Operating Income | -$137,110 | -$138,053 | $130,528 | -$215,633 |
| % Margin | -179.7% | -181.6% | 31.6% | -808.2% |
| Other Income/Exp. Net | $20,499 | $18,811 | $4,706 | $3,274 |
| Pre-Tax Income | -$116,611 | -$119,242 | $135,234 | -$212,359 |
| Tax Expense | $6,084 | -$568 | $10,893 | -$516 |
| Net Income | -$122,695 | -$118,674 | $124,341 | -$211,843 |
| % Margin | -160.8% | -156.1% | 30.1% | -794% |
| EPS | -1.62 | -1.72 | 1.91 | -4.06 |
| % Growth | 5.8% | -190.1% | 147% | – |
| EPS Diluted | -1.62 | -1.72 | 1.9 | -4.06 |
| Weighted Avg Shares Out | 75,847 | 68,863 | 65,195 | 52,132 |
| Weighted Avg Shares Out Dil | 75,879 | 68,863 | 65,249 | 52,132 |
| Supplemental Information | – | – | – | – |
| Interest Income | $19,941 | $19,705 | $3,596 | $1,965 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $11,193 | $17,305 | $12,004 | $9,583 |
| EBITDA | -$108,624 | -$120,702 | $142,490 | -$206,089 |
| % Margin | -142.4% | -158.8% | 34.5% | -772.4% |